Effects of electroconvulsive therapy on hypothalamic-pituitary-thyroid axis activity in depressed patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 6, 2002, Pages 1171-1175

  Esel, Ertugrul ^a   Turan, Tayfun ^a   Kula, Mustafa ^a   Reyhancan, Mustafa ^a   Gonul, Ali ^a   Basturk, Mustafa ^a   Sofuoglu, Seher ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Depression; Electroconvulsive therapy; Hypothalamic pituitary thyroid axis; Neuroendocrine; Thyroid stimulating hormone; Thyroxine

Indexed keywords

LIOTHYRONINE; PROPOFOL; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; ELECTROCONVULSIVE THERAPY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENERAL ANESTHESIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAJOR DEPRESSION; MALE; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; BIPOLAR DISORDER; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY GLAND; PSYCHIATRIC STATUS RATING SCALES; RADIOIMMUNOASSAY; THYROID GLAND; THYROID HORMONES;

EID: 0036776213     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(02)00256-7     Document Type: Article

References (31)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. 1994;American Psychiatric Association, Washington, DC.
2. Aperia B., Bergman H., Engelbrektson K., Thoren M., Wetterberg L. Effects of electroconvulsive therapy on neuropsychological function and circulating levels of ACTH, cortisol, prolactin, and TSH in patients with major depressive illness. Acta Psychiatr. Scand. 72:1985;536-541.
3. Callahan A.M., Frye M.A., Marangell L.B., George M.S., Ketter T.A., L'Herrou T., Post R.M. Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics. Biol. Psychiatry. 41:1997;264-272.
4. Deakin J.F.W., Ferrier I.N., Crow T.J., Johnstone E.C., Lawler P. Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcome. Br. J. Psychiatry. 143:1983;618-624.
5. Dykes S., Scott A.I.F., Gow S.M., Whalley L.J. Effects of seizure duration on serum TSH concentration after ECT. Psychoneuroendocrinology. 12:1987;477-482.
6. Fink M., Nemeroff C. A neuroendocrine view of ECT. Convuls. Ther. 5:1989;296-304.
7. Grosvenor C.E., Mena F. Evidence that thyrotropin-releasing hormone and a hypothalamic prolactin-releasing factor may function in the release of prolactin in the lactating rat. Endocrinology. 107:1980;863-868.
8. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-61.
9. Kim S.Y., Post R.M., Rosen J.B. Differential regulation of basal and kindling-induced TRH mRNA expression by thyroid hormone in the hypothalamic and limbic structures. Neuroendocrinology. 63:1996;297-304.
10. Kirkegaard C., Faber J. Influence of free thyroid hormone levels on the TSH response to TRH in endogenous depression. Psychoneuroendocrinology. 11:1986;491-497.
11. Kubek M.J., Meyerhoff J.L., Hill T.G., Norton J.A., Sattin A. Effects of subconvulsive and repeated electroconvulsive shock on thyrotropin-releasing hormone in rat brain. Life Sci. 36:1985;315-320.
12. Lloyd R.L., Pekary A.E., Sattin A., Amundson T. Antidepressant effects of thyrotropin-releasing hormone analogues using a rodent model of depression. Pharmacol. Biochem. Behav. 70:2001;15-22.
13. Maes M., Schotte C., Vandewoude M., Martin M., Blockx P. TSH responses to TRH as a function of basal serum TSH: relevance for unipolar depression in females - a multivariate study. Pharmacopsychiatry. 25:1992;136-144.
14. Maes M., Meltzer H.Y., Cosyns P., Suy E., Schotte C. An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: results of a large-scaled and correlated study. Psychoneuroendocrinology. 18:1993;607-620.
15. Marangell L.B., George M.S., Callahan A.M., Ketter T.A., Pazzaglia P.J., L'Herrou T.A., Leverich G.S., Post R.M. Effects of intrathecal thyrotropin-releasing hormone (pirotirelin) in refractory depressed patients. Arch. Gen. Psychiatry. 54:1997;214-222.
16. McGarvey K.A., Zis A.P., Brown E.E., Nomikos G.G., Fibiger H.C. ECS-induced dopamine release: effects of electrode placement, anticonvulsant treatment, and stimulus intensity. Biol. Psychiatry. 34:1993;152-157.
17. Modigh K. Long-term effects of electroconvulsive shock therapy on synthesis turnover and uptake of brain monoamines. Psychopharmacology. 49:1976;179-185.
18. Musselman D.L., Nemeroff C.B. Depression and endocrine disorders: focus on the thyroid and adrenal system. Br. J. Psychiatry. Suppl. June(30):1996;123-128.
19. Nerozzi D., Graziosi S., Melia E., Aceti F., Magnani A., Fiume S., Fraioli F., Frajese G. Mechanism of action of ECT in major depressive disorders: a neuroendocrine interpretation. Psychiatry Res. 20:1987;207-213.
20. Papakostas Y., Markianos M., Papadimitriou G., Stefanis C. Thyrotropin and prolactin secretion during ECT: implications for the mechanism of ECT action. Convuls. Ther. 6:1990;214-220.
21. Papakostas Y., Markianos M., Papadimitriou G., Lykouras L., Stefanis C. Thyrotropin and prolactin responses to ECT in schizophrenia and depression. Psychiatry Res. 37:1991;5-10.
22. Pekary A.E., Sattin A., Lloyd R.L. Electroconvulsive seizures increase levels of PS4, the TRH-enhancing peptide [prepro-TRH(160-169)], in rat brain. Neuroendocrinology. 65:1997;377-384.
23. Sattin A. The role of TRH and related peptides in the mechanism of action of ECT. J. ECT. 15:1999;76-92.
24. Sattin A., Pekary A.E., Lloyd R.L. TRH gene products are implicated in the antidepressant mechanisms of seizures. Ann. N.Y. Acad. Sci. 739:1994;135-153.
25. Skrabanek P., Balfe A., Webb M., Maguire J., Powell D. Electroconvulsive therapy (ECT) increases plasma growth hormone, prolactin, luteinizing hormone and follicle stimulating hormone but not thyrotropin or substance P. Psychoneuroendocrinology. 6:1981;261-267.
26. Snaith R.P., Baugh S.J., Clayden A.D., Husain A., Sipple M.A. The Clinical Anxiety Scale: an instrument derived from the Hamilton Anxiety Scale. Br. J. Psychiatry. 141:1982;518-523.
27. Swartz C.M. Neuroendocrine effects of electroconvulsive therapy (ECT). Psychopharmacol. Bull. 33:1997;265-271.
28. Tauboll E., Gjerstad L., Stokke K.T., Lundervold A., Telle B. Effects of electroconvulsive therapy (ECT) on thyroid function parameters. Psychoneuroendocrinology. 12:1987;349-354.
29. Whalley L.J., Rosie R., Dick H., Levy G., Watts A.G., Sheward W.J., Christie J.E., Fink G. Immediate increases in plasma prolactin and neurophysin but not other hormones after electroconvulsive therapy. Lancet. 1982;1064-1068.
30. Whalley L.J., Eagles J.M., Bowler J.M.R., Bennie J.G., Dick H.R., McGuire R.J., Fink G. Selective effects of ECT on hypothalamic pituitary activity. Psychol. Med. 17:1987;312-328.
31. Yoshida K., Higuchi H., Kamata M., Yoshimoto M., Shimizu T., Hishikawa Y. Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats. Prog. Neuropsychopharmacol. Biol. Psychiatry. 22:1998;435-444.